Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Metabolite of dietary soy may lower risk factor for dementia

Metabolite of dietary soy may lower risk factor for dementia

Scientists uncover a novel cellular mechanism for disposing of misfolded proteins

Scientists uncover a novel cellular mechanism for disposing of misfolded proteins

New vaccine targeting toxic Aβ may offer clinical benefit in treating Alzheimer's disease

New vaccine targeting toxic Aβ may offer clinical benefit in treating Alzheimer's disease

WSU scientists develop new method to detect Alzheimer's biomarkers

WSU scientists develop new method to detect Alzheimer's biomarkers

New model of human brain networks sheds light on how the brain functions

New model of human brain networks sheds light on how the brain functions

New method makes the superficial white matter visible in the living human brain

New method makes the superficial white matter visible in the living human brain

Scientists lay out a novel rationale for COVID-19 drug design

Scientists lay out a novel rationale for COVID-19 drug design

Tracing lineage to demonstrate direct astrocyte-to-neuron conversion in mouse brain

Tracing lineage to demonstrate direct astrocyte-to-neuron conversion in mouse brain

Alzheimer's disease: Impaired blood flow in the brain correlated with tau buildup

Alzheimer's disease: Impaired blood flow in the brain correlated with tau buildup

Glutathione precursor improves multiple deficits associated with premature aging

Glutathione precursor improves multiple deficits associated with premature aging

Researchers are working to advance device for detecting ultra-low levels of disease particles

Researchers are working to advance device for detecting ultra-low levels of disease particles

Researchers use AI methods to 'redefine' Alzheimer's disease

Researchers use AI methods to 'redefine' Alzheimer's disease

Scientists examine a novel approach to analyzing dendritic spine shapes

Scientists examine a novel approach to analyzing dendritic spine shapes

Drug derived from a natural human protein could stop lethal lung damage from the flu

Drug derived from a natural human protein could stop lethal lung damage from the flu

Study: Deaths recorded during pandemic is higher than those attributed to COVID-19

Study: Deaths recorded during pandemic is higher than those attributed to COVID-19

Even light physical activity can significantly boost health, shows study

Even light physical activity can significantly boost health, shows study

Enzyme SSH1 impairs the disposal of damaged tau and neurotoxic mitochondria

Enzyme SSH1 impairs the disposal of damaged tau and neurotoxic mitochondria

Chemists suggest a new domino reaction to produce organic compounds against cancers

Chemists suggest a new domino reaction to produce organic compounds against cancers

Neurobiologists decode central mechanism of degenerative processes in brains of mouse models

Neurobiologists decode central mechanism of degenerative processes in brains of mouse models

Impaired blood flow to brain regions linked with tau buildup in Alzheimer’s disease

Impaired blood flow to brain regions linked with tau buildup in Alzheimer’s disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.